Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROSUVASTATIN vs SIMVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROSUVASTATIN vs SIMVASTATIN: Safety Overview

Metric ROSUVASTATIN SIMVASTATIN
Total FAERS Reports 36,332 27,079
Deaths Reported 1,536 2,792
Death Rate 4.2% 10.3%
Hospitalizations 11,195 8,824
Average Patient Age 66.1 yrs 66.6 yrs
% Female Patients 54.9% 47.5%
FDA Approval Date Apr 1, 2020 Apr 14, 2009
Manufacturer Umedica Laboratories USA Inc. Aphena Pharma Solutions - Tennessee, LLC
Route ORAL ORAL
Marketing Status Prescription Prescription